Across TCGA pan-cancer cohorts, VENTXP7 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of VENTXP7’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where VENTXP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types VENTXP7 is over-expressed in tumor.
KIRC and THCA are the cancer types where VENTXP7 tumor–normal differential expression is most reproducible.